What is Manhattan Labs?
Manhattan Labs operates as a premier service-oriented independent clinical laboratory within the New York City metropolitan area. The company distinguishes itself by integrating advanced clinical laboratory technology with personalized service, exceptional turnaround times, and easily accessible results. This approach aims to elevate industry standards and set new benchmarks for service excellence in the laboratory sector.
How much funding has Manhattan Labs raised?
Manhattan Labs has raised a total of $4M across 2 funding rounds:
Other Financing Round
$3.7M
Debt
$350K
Other Financing Round (2013): $3.7M with participation from Trevi Health Ventures
Debt (2020): $350K led by PPP
Key Investors in Manhattan Labs
Trevi Health Ventures
Trevi Health Ventures is a specialist investment firm focused on healthcare, providing alternative asset management through private equity funds globally. They offer development and growth capital for private healthcare companies, with a particular emphasis on medical devices, biopharmaceuticals, and healthcare services.
PPP
Public-Private Partnership
What's next for Manhattan Labs?
The substantial enterprise-level funding context suggests Manhattan Labs is poised for significant scaling and operational expansion. Future strategic initiatives will likely focus on enhancing technological capabilities, broadening service offerings, and potentially expanding its geographic reach. Continued investment in innovation and service quality will be critical for maintaining its competitive edge and achieving long-term growth objectives.
See full Manhattan Labs company page
